SINGAPORE (AP) _ Wave Life Sciences Pte. Ltd. (WVE) on Monday reported a loss of $41.9 million in its second quarter.
On a per-share basis, the Singapore-based company said it had a loss of $1.22.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.05 per share.
The biopharmaceutical company posted revenue of $7.6 million in the period, also falling short of Street forecasts. Five analysts surveyed by Zacks expected $15.8 million.
Wave Life Sciences shares have fallen 54% since the beginning of the year. In the final minutes of trading on Monday, shares hit $19.35, a drop of 50% in the last 12 months.